European anti-counterfeit scheme moves on amid industry concerns
This article was originally published in Scrip
Executive Summary
The Council of Europe's department for the quality of medicines (EDQM) is working on a "track-and-trace" project that it says will be able to link up national traceability systems in a Europe-wide platform to help prevent counterfeit medicines entering the supply chain. However, the European pharmaceutical industry association and other players have expressed concern over the costs and practicalities of implementing such a system.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.